BioXconomy

Latest News

Eyes on Asia: AirNexis, AstraZeneca, Syngene International

Jan 21, 2026

Robot synergy of AI technology, shape of head with word AI in middle

Synbio hires Resonance Health unit for AI facial screening tech trial to detect mental health disorders

Jan 20, 2026

GSK written on a phone in orange with black background

GSK to acquire RAPT in $2.2bn deal, expanding pipeline with food allergy treatment

Jan 20, 2026

Man pointing to the word acquisition

Boston Scientific buys Penumbra in $14.5bn cardiovascular-focused deal

Jan 19, 2026

The panelists discussing women's health at Biotech Showcase in San Francisco, California

Women’s health is opening new doors in science and investment, say experts

Women’s health is opening new doors in science and investment, say experts

Panelists discussed how women’s health is not just a moral imperative, but a transformative business opportunity poised to potentially redefine healthcare.

Clinical Trials

China’s clinical trial reforms create new opportunities for global CROs and drugmakers

China trial reforms boost CRO opportunities

Jan 21, 2026

Black and white 3D rendering of lymphocyte and antibodies

Can AI outperform nature? Artificial antibodies are being put to the test

Can AI outperform nature? Artificial antibodies are being put to the test

Jan 20, 2026

Interviews

Meena Datta and Meghan Weinberg headshots

Compliance, Regulatory and Legal

Strategic distribution choices for rare disease manufacturers: Navigating licensure and compliance challenges

Rare Disease Makers Face 3PL Distribution

Jeffrey Whitford, VP of sustainability and social business innovation at MilliporeSigma

Sustainability through partnerships: MilliporeSigma’s green chemistry initiative

Sustainability through partnerships: MilliporeSigma’s green chemistry initiative

Subscribe to Our Newsletters

Expert insights without the effort! Stay ahead of the curve with our free, topic-specific enewsletters delivered straight to your inbox.

News from APAC

Eyes on Asia: AirNexis, AstraZeneca, Syngene International Eyes on Asia: AirNexis, AstraZeneca, Syngene International

AbbVie and China’s RemeGen kick off year with $5.6bn oncology deal AbbVie and China’s RemeGen kick off year with $5.6bn oncology deal

byMillie Nelson

AI in Life Sciences

More on life sciences AI

Robot synergy of AI technology, shape of head with word AI in middle

Synbio hires Resonance Health unit for AI facial screening tech trial to detect mental health disorders Synbio starts AI mental health trial

byGareth Macdonald

Black and white 3D rendering of lymphocyte and antibodies

Can AI outperform nature? Artificial antibodies are being put to the test Can AI outperform nature? Artificial antibodies are being put to the test

Acquire - Hand pressing a button on blurred background concept

RWD analytics firm Verana Health buys COTA Healthcare for $52m Verana buys COTA Healthcare for $52M

byGareth Macdonald

Deep Intelligent Pharma raises $50m to advance AI clinical trial automation technology DIP raises $50M for AI clinical tech

byGareth Macdonald

AI in Healthcare, Revolutionizing Medical Diagnostics and Patient Care

Less delays, more lifesaving therapies: How AI agents are transforming the clinical trial process for CRAs How AI agents are transforming the clinical trial process for CRAs

byAndrew Mackinnon, executive general manager, Medable

Mallet On Open Legal Book

Incoming ACRO chair says CROs are influencing AI regulation development ACRO names Fortrea exec Kennedy as new chair

byGareth Macdonald

AI management concept

AI isn’t going anywhere, finance experts say AI isn’t going anywhere, finance experts say

byBrandy Fidler

AI hand over the earth with a warning sign concept art

Former regulator warns pharma of AI enforcement risks AI risks hit pharma after settlement

byBrandy Fidler

abstract background with gears and gear wheels

ICON plans $300m investment in AI and digital innovation over next three years ICON invests $300m in AI over three years

byGareth Macdonald

digital clipboard with checklist

Experts call for framework to identify where AI adds most value in trials Selective AI use urged for clinical trials

byGareth Macdonald

Chalkboard with funding written and dollars

Iambic raises $100m to advance AI drug discovery platforms Iambic raises $100m to advance AI drug discovery platforms

Businessman using AI on laptop

Biotech finance leaders caution: AI effectiveness hinges on processes, clean data, skilled people AI needs solid foundation in biotech finance

byBrandy Fidler

More on life sciences AI

BIO-Europe 2025: Company Presentations

Jantar presents at BIO-Europe 2025

Sponsored Content

Jantar GmbH Presents Dicholine Succinate, a New Non-Prescription Drug for the Treatment of Chronic Rhinosinusitis

Jantar GmbH's non-prescription drug for the treatment of chronic rhinosinusitis

Nov 12, 2025|8 Mins View

More from BIO-Europe 2025